Cargando…
Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
BACKGROUND: Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic acid. He...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487815/ https://www.ncbi.nlm.nih.gov/pubmed/34520129 http://dx.doi.org/10.1111/1759-7714.14147 |
_version_ | 1784578032056401920 |
---|---|
author | Xu, Jiaqi Wang, Lujuan Yin, Na Chen, Anqi Yi, Junqi Tang, Jingqun Xiang, Juanjuan |
author_facet | Xu, Jiaqi Wang, Lujuan Yin, Na Chen, Anqi Yi, Junqi Tang, Jingqun Xiang, Juanjuan |
author_sort | Xu, Jiaqi |
collection | PubMed |
description | BACKGROUND: Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic acid. Here, we aimed to study the molecular alterations and proteomic characteristics of EPV in dormant and reactivated cancer cells induced by cisplatin. METHODS: We used a short‐term single dose of cisplatin to induce the dormant and reactivated cell status. We examined the gene expressional profiling and proteomic profiling of EVPs from dormant and reactivated cancer cells by RNA‐sequencing and LC–MS/MS. RESULTS: We found substantial changes in gene expression and protein level in EVP. The genes with higher expression in dormant cancer cells were lipid transporter‐ and lipid metabolic‐related genes. A total of 111 EVP proteins were upregulated in dormant cancer cells compared to those in control cells. Fifty differential expressed proteins (DEPs) were identified in EVPs from reactivated cancer cells compared to those in dormant cancer cells. Among the DEPs, we found that apolipoproteins such as APOA1 and APOE were significantly increased in dormant cancer cell‐derived EVPs. Integration of EVP proteomes with transcriptional profiles of cancer cells revealed that the proteomic profiling of EVP derived from cancer cells can reflect the cellular status of cancer cells, which showed an activated lipid metabolism in dormant state. CONCLUSION: Lipoproteins enriched in EVPs reflect the activated lipid metabolism in dormant cancer cells and may provide potential biomarkers or therapeutic targets for cisplatin‐based therapy. |
format | Online Article Text |
id | pubmed-8487815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-84878152021-10-08 Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC Xu, Jiaqi Wang, Lujuan Yin, Na Chen, Anqi Yi, Junqi Tang, Jingqun Xiang, Juanjuan Thorac Cancer Original Articles BACKGROUND: Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic acid. Here, we aimed to study the molecular alterations and proteomic characteristics of EPV in dormant and reactivated cancer cells induced by cisplatin. METHODS: We used a short‐term single dose of cisplatin to induce the dormant and reactivated cell status. We examined the gene expressional profiling and proteomic profiling of EVPs from dormant and reactivated cancer cells by RNA‐sequencing and LC–MS/MS. RESULTS: We found substantial changes in gene expression and protein level in EVP. The genes with higher expression in dormant cancer cells were lipid transporter‐ and lipid metabolic‐related genes. A total of 111 EVP proteins were upregulated in dormant cancer cells compared to those in control cells. Fifty differential expressed proteins (DEPs) were identified in EVPs from reactivated cancer cells compared to those in dormant cancer cells. Among the DEPs, we found that apolipoproteins such as APOA1 and APOE were significantly increased in dormant cancer cell‐derived EVPs. Integration of EVP proteomes with transcriptional profiles of cancer cells revealed that the proteomic profiling of EVP derived from cancer cells can reflect the cellular status of cancer cells, which showed an activated lipid metabolism in dormant state. CONCLUSION: Lipoproteins enriched in EVPs reflect the activated lipid metabolism in dormant cancer cells and may provide potential biomarkers or therapeutic targets for cisplatin‐based therapy. John Wiley & Sons Australia, Ltd 2021-09-14 2021-10 /pmc/articles/PMC8487815/ /pubmed/34520129 http://dx.doi.org/10.1111/1759-7714.14147 Text en © 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Xu, Jiaqi Wang, Lujuan Yin, Na Chen, Anqi Yi, Junqi Tang, Jingqun Xiang, Juanjuan Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC |
title | Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
|
title_full | Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
|
title_fullStr | Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
|
title_full_unstemmed | Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
|
title_short | Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC
|
title_sort | proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in nsclc |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487815/ https://www.ncbi.nlm.nih.gov/pubmed/34520129 http://dx.doi.org/10.1111/1759-7714.14147 |
work_keys_str_mv | AT xujiaqi proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT wanglujuan proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT yinna proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT chenanqi proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT yijunqi proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT tangjingqun proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc AT xiangjuanjuan proteomicprofilingofextracellularvesiclesandparticlesrevealsthecellularresponsetocisplatininnsclc |